NOBEL BIOCARE DANMARK A/S: Financial statements 2014
CVR: 28293364
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
NOBEL BIOCARE DANMARK A/S (CVR 28293364) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 5,214,467 and a net result of DKK 429,847 compared with DKK 298,710 the year before. That is a decrease of 1.2% compared with the year before. Equity in the 2014 report amounted to DKK 2,383,435. The solvency ratio was 48.5%.
- Gross Profit
- DKK 5,214,467
- Profit/Loss
- DKK 429,847
- Equity
- DKK 2,383,435
- Total Assets
- DKK 4,913,780
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 5.2 mio. | 430 t. | 2.4 mio. | - |
| 2013 | - | 5.3 mio. | 299 t. | 2 mio. | - |
| 2012 | - | 6.1 mio. | 409 t. | 4.7 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of June 18, 2014, Hans Tobias Nordefjäll has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of June 18, 2014, Jens Henrik Nedoh has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of June 18, 2014, Karl Magnus Persson has left the board of directors of NOBEL BIOCARE DANMARK A/S.
NOBEL BIOCARE DANMARK A/S has published its annual report for 2013. Gross profit came to DKK 5,277,883, and the net result was DKK 298,710.
About NOBEL BIOCARE DANMARK A/S
NOBEL BIOCARE DANMARK A/S is a Danish company of the type Aktieselskab based in Silkeborg, founded in 2004. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Jan Jerne. The board consists of Magnus Karl Andreas Pettersson (chair), Harrieth Eva Elisabeth Sundaeus and Jan Jerne. The company is owned by Nobel Biocare AB. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,044,322 and a net result of DKK -4,810,707 compared with DKK -4,496,854 the year before. Equity in the 2025 report amounted to DKK -10,951,798.